Article Information
History
- November 20, 2018.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Christopher R. M. Asquith§,‡,*,
- Kaleb M. Naegeli⊥,
- Michael P. East‡,
- Tuomo Laitinen†,
- Tammy M. Havener⊥,
- Carrow I. Wells§,
- Gary L. Johnson‡,
- David H. Drewry§,
- William J. Zuercher§^ and
- David C. Morris⊥,*
- §Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
- ‡Department of Pharmacology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
- ⊥UNC Catalyst for Rare Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
- †School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, 70211 Kuopio, Finland
- ^Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
- ↵*Corresponding Author chris.asquith{at}unc.edu, +1 (919) 962-5349 dave.morris{at}unc.edu +1 (919) 445-2750